Behavioral Health Business September 18, 2023
Key Drug Enforcement Administration (DEA) leaders said little last week during the roughly 11 hours of live presentations heard over two days of listening sessions regarding the future of telehealth and prescribing controlled substances.
What they did say, however, helps clarify what is top of mind for the DEA as the agency considers re-approaching how to regulate the prescription of controlled substances via telehealth. DEA leaders who participated in the listening sessions included Administrator Anne Milgram, Deputy Assistant Administrators Tom Prevoznik and Matthew Strait.
On their end, Milgram and Prevoznik were limited to only asking clarifying questions germane to presentations. Those questions largely focused on asking presenters to flesh out several ideas related to patient safety and prescription drug diversion...
Today's Sponsors
Today's Sponsor